Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
<p dir="ltr">Lactate dehydrogenase C (LDHC) is an archetypical cancer testis antigen with limited expression in adult tissues and re-expression in tumors. This restricted expression pattern together with the important role of LDHC in cancer metabolism renders LDHC a potential target...
محفوظ في:
| المؤلف الرئيسي: | Remy Thomas (702843) (author) |
|---|---|
| مؤلفون آخرون: | Hibah Shaath (5599658) (author), Adviti Naik (673163) (author), Salman M. Toor (8854751) (author), Eyad Elkord (5396390) (author), Julie Decock (44558) (author) |
| منشور في: |
2020
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer
حسب: A. Naik (7783220)
منشور في: (2023) -
Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy
حسب: Adviti Naik (673163)
منشور في: (2021) -
Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer
حسب: Adviti Naik (673163)
منشور في: (2025) -
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
حسب: Remy Thomas (702843)
منشور في: (2018) -
Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?
حسب: Ghaneya Al-Khadairi (14153274)
منشور في: (2019)